Thoracic manifestations of Castleman's disease;Maladie de Castleman à expression thoracique

Revue de Pneumologie Clinique

Volumn 65, Issue 2, 2009, Pages 101-107

  Degot T ^a   Metivier A C ^a   Casnedi, S ^b   Chenard, M P ^b   Kessler, R ^a  

^a HÔPITAL CIVIL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Castleman's disease; Giant lymph node hyperplasia; Lymph nodes; Lymphoma; Mediastinum

Indexed keywords

CORTICOSTEROID; PRISTINAMYCIN; PYRIDOSTIGMINE; RITUXIMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AXILLARY LYMPH NODE; BIOPSY; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SURVEILLANCE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LUNG BIOPSY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; MEDIASTINUM; MEDIASTINUM LYMPH NODE; MYASTHENIA GRAVIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; LUNG; PATHOLOGY; THORAX DISEASE;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOLOGIC FACTORS; LUNG; MALE; THORACIC DISEASES;

EID: 67449101269     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2008.12.004     Document Type: Article

References (21)

1. Castleman B., and Towne V. Case records of the Massachusetts general hospital : Case No. 40231. N Engl J Med 250 (1954) 1001-1005
2. Herrada J., Cabanillas F., Rice L., Manning J., and Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128 (1998) 657-662
3. Sarrot-Reynauld F., Cacoub P., and Le groupe français d'étude de la maladie de Castleman. Maladie de Castleman : étude préliminaire d'une cohorte nationale de 67 cas. Rev Med Interne 19 (1998) 413S
4. Rose C., Mahieu M., Hachulla E., Facon T., Hatron P.Y., Bauters F., et al. Le POEMS syndrome. Rev Med Interne 18 (1997) 553-562
5. Day J.R., Bew D., Ali M., Dina R., and Smith P.L. Castleman's disease associated with myasthenia gravis. Ann Thorac Surg 75 (2003) 1648-1650
6. Chen K.T. Multicentric Castleman 's disease and Kaposi's sarcoma. Am J Surg Pathol 8 (1984) 287-293
7. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 (1995) 1276-1280
8. Stebbing J., Pantanowitz L., Dayyani F., Sullivan R.J., Bower M., and Dezube B.J. HIV-associated multicentric Castleman's disease. Am J Hematol 83 (2008) 498-503
9. Du M.Q., Bacon C.M., and Isaacson P.G. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol 60 (2007) 1350-1357
10. Ascoli V, Signoretti S, Onetti-Muda A, Pescarmona E, Della-Rocca C, Nardi F, et al. Primary effusion lymphoma in HIV-infected patients with multicentric Castleman's disease 2001;193:200-9.
11. Oksenhendler E., Boulanger E., Galicier L., Du M.Q., Dupin N., Diss T.C., et al. High incidence of kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99 (2002) 2331-2336
12. Liu W., Lacouture M.E., Jiang J., Kraus M., Dickstein J., Soltani K., et al. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol 33s (2006) 46-51
13. Nishi J., and Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman' disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma 38 (2000) 387-394
14. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129 (2005) 3-17
15. Ko S.F., Hsieh M.J., Ng S.H., Lin J.W., Wan Y.L., Lee T.Y., et al. Imaging spectrum of Castleman's disease. AJR Am J Roentgenol 182 (2004) 769-775
16. Enomoto K., Nakamichi I., Hamada K., Inoue A., Higuchi I., Sekimoto M., et al. Unicentric and multicentric Castleman's disease. Br J Radiol 80 (2007) e24-e26
17. Parrot A., Bazelly B., Milleron B.J., Carette M.F., Georges O., and Akoun G.M. Localisation thoracique inhabituelle d'une tumeur de Castleman. À propos d'une observation. Rev Pneumol Clin 45 (1989) 168-170
18. Guihot A., Couderc L.J., Agbalika F., Galicier L., Bossi P., Rivaud E., et al. Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study. Eur Respir J 26 (2005) 118-125
19. Chronowski G.M., Ha C.S., Wilder R.B., Cabanillas F., Manning J., and Cox J.D. Treatment of unicentric and multicentric Castleman's disease and the role of radiotherapy. Cancer 92 (2001) 670-676
20. Marcelin A.G., Aaron L., Mateus C., Gyan E., Gorin I., Viard J.P., et al. Rituximab therapy for HIV-associated Castleman's disease. Blood 102 (2003) 2786-2788
21. Ide M., Kawachi Y., Izumu Y., Kasaki K., and Ogino T. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab. Eur J Haematol 76 (2006) 119-123